Inspection Record

Kings Park Slope Inc — FDA 483 Findings

US FDAInspected 2018-09-14Published 2019-04-30 4 findingsAseptic processing and sterility assuranceEquipment and facility

Inspectors Rachael A MoliverThe inspectors who signed the published document.Inspector lookup

View the regulator's official source The source document is always the basis for judgement.

Findings

1Aseptic processing and sterility assurance

Disinfecting agents and cleaning wipes used in the ISO 5 classified aseptic processing areas were not sterile.

2Aseptic processing and sterility assurance

The use of sporicidal agents in the ISO 5 classified aseptic processing area was inadequate.

3Equipment and facility

Your facility design allowed the influx o fpoor quality air into a higher classified area.

4Aseptic processing and sterility assurance

Media fills were not performed that closely simulate aseptic production operations incorporating as appropriate, worst-case activities and conditions that provide a challenge to aseptic operations.

About this record

Extracted automatically from the document US FDA published on 2019-04-30. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

Kings Park Slope Inc company profile — full history US FDA documents, 2019 Go to Findings search